Gulf Lloyds (India)
- Issue price
- ₹ 100
- Issue size
- ₹ 18.19 Cr.
- Min. investment
- ₹ 1,20,000
- Listing price
- ₹ 100
- Subscribed
- 10.9x
- Lot size
- 1,200 shares
- P/E
- 15.64
- RoNW
- 31.92%
- RoCE
- 24.88%
- EPS
- ₹ 6.39
- Promoter stake
- 72.92%
Timeline
- doneOpens20 Jul
- doneCloses22 Jul
- doneAllotment23 Jul
- doneListing27 Jul
Grey market premium (GMP)
GMP is an unofficial premium from the unregulated grey market. It is not published, verified or regulated by SEBI, NSE or BSE, grey market deals are not legally enforceable, and it is not a reliable indicator of the listing price. Do not apply for an IPO on the basis of GMP. It is not a recommendation of Minerva Capital Research Solutions.
- Highest
- ₹ 25 on 19 Jul 2026
- Lowest
- ₹ 1 on 22 Jul 2026
- First quoted
- ₹ 3 on 14 Jul 2026
Subscription
How many times each investor group bid for its share, as of 22 Jul 2026, 05:10 PM IST.
How much to apply for
The smallest and largest bids for each kind of investor at the upper price band.
| Retail (Min) | 1 | 1,200 | ₹ 1,20,000 |
| Retail (Max) | 1 | 1,200 | ₹ 1,20,000 |
| HNI (Min) | 2 | 2,400 | ₹ 2,40,000 |
Company overview
Financials
| Assets | 35.29 |
| Total Income | 35.97 |
| Profit After Tax | 4.3 |
| EBITDA | 7.9 |
| NET Worth | 13.48 |
| Reserves and Surplus | 8.71 |
| Total Borrowing | 15.68 |
What the money is for
| Capital Expenditure for Office premises | 4.01 |
| Repayment of unsecured loans | 3 |
| Working Capital requirement | 7.15 |
| General corporate purposes | — |
Promoters
- Jaykumar Bhavsar
- Bhagirath Bhavsar
- Anitaben Bhavsar
- Shivaniben Bhavsar
Registrar, lead managers and documents
- Listing on
- BSE SME
- Face value
- ₹ 10 a share
- Registrar
- KFin Technologies Limited
- Lead managers
- Interactive Financial Services Ltd.
IPO dates, prices, grey market premium (GMP), subscription and the company overview: IPO Guru, updated three times a day. GMP is an unofficial premium from the unregulated grey market. It is not published, verified or regulated by SEBI, NSE or BSE, grey market deals are not legally enforceable, and it is not a reliable indicator of the listing price. Do not apply for an IPO on the basis of GMP. It is not a recommendation of Minerva Capital Research Solutions.
Our recommendations are research opinions, not investment advice. Read the offer document (RHP) and consult your financial adviser before investing.